Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 3 , Pages 201-204 , June 2007

Premenstrual Dysphoric Disorder in an Adolescent Female

References 

  1. Mishell DR. Premenstrual disorders: epidemiology and disease burden. Am J Manag Care. 2005;11(16 Suppl):S473
  2. Premenstrual dysphoric disorder. In: Diagnostic and Statistical Manual of Mental Disorders. 4th, Text Revision ed. Washington, DC: American Psychiatric Association; 2000;p. 771
  3. Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology. 2003;28(Suppl 3):25
  4. Ross LE, Steiner M. A biopsychosocial approach to premenstrual dysphoric disorder. Psychiatr Clin North Am. 2003;26:529
  5. Halbreich U, Borenstein J, Pearlstein T, et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneurondocrinology. 2003;28(Suppl 3):1
  6. Tabassum S, Afridi B, Aman Z, et al. Premenstrual syndrome: frequency and severity in young college girls. J Pak Med Assoc. 2005;55:546
  7. Warnock JK, Clayton AH. Chronic episodic disorders in women. Psychiatr Clin North Am. 2003;26:725
  8. Backstrom T, Andersson A, Andree L, et al. Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci. 2003;1007:42
  9. Girdler SS, Straneva PA, Light KC, et al. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry. 2001;49:788
  10. Rapkin AJ, Edelmuth E, Chang LC, et al. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol. 1987;70:533
  11. Wihlback AC, Sundstrom Poromaa I, et al. Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding. Psychoneuroendocrinology. 2004;29:757
  12. Bang LM, Keating GM. Paroxetine controlled release. CNS Drugs. 2004;18:355
  13. Freeman EW. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder. CNS Drugs. 2004;18:453
  14. Luisi AF, Pawasauskas JE. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors. Pharmacotherapy. 2003;23:1131
  15. Pearlstein T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?. Drugs. 2002;62:1869
  16. Steiner M, Born L. Diagnosis and treatment of premenstrual dysphoric disorder: an update. Int Clin Psychopharmacol. 2000;15(Suppl 3):S5
  17. Steiner M, Pearlstein T, Cohen LS, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006;15:57
  18. Rapkin AJ, Mikacich JA. Premenstrual syndrome in adolescents: diagnosis and treatment. Pediatr Endocrinol Rev. 2006;3(Suppl 1):132
  19. Silber TJ, Valadez-Meltzer A. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature. J Adolesc Health. 2005;37:518
  20. Wittchen HU, Becker E, Lieb R, et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32:119
  21. Cohen LS, Miner C, Brown EW, et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol. 2002;100:435
  22. Pearlstein T, Joliat MJ, Brown EB, et al. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment. Am J Obstet Gynecol. 2003;188:887
  23. Endicott J, Amsterdam J, Eriksson E, et al. Is premenstrual dysphoric disorder a distinct clinical entity?. J Womens Health Gend Based Med. 1999;8:663
  24. Reape KZ. Current contraceptive research and development. Adolesc Med Clin. 2005;16:617
  25. Freeman EW, Kroll R, Rapkin A, et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med. 2001;10:561
  26. Freeman EW. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder. Eur J Contracept Reprod Health Care. 2002;7(Suppl 3):27
  27. Kroll R, Rapkin AJ. Treatment of premenstrual disorders. J Reprod Med. 2006;51(4 Suppl):359

PII: S1083-3188(06)00279-8

doi: 10.1016/j.jpag.2006.09.014

Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 3 , Pages 201-204 , June 2007

Article Tools